Cardiopulmonary bypass increases plasma bradykinin concentrations

Immunopharmacology

Volumn 43, Issue 2-3, 1999, Pages 145-147

  Cugno, M ^a   Nussberger, J ^b   Biglioli, P ^a   Giovagnoni, M G ^a   Gardinali, M ^a   Agostoni, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE

Author keywords

Bradykinin; Cardiopulmonary bypass; Catabolism

Indexed keywords

BRADYKININ; COMPLEMENT; CYTOKINE; TUMOR NECROSIS FACTOR;

BLOOD CLOTTING; BLOOD PRESSURE; BLOOD VESSEL PERMEABILITY; CARDIOPULMONARY BYPASS; CATABOLISM; CLINICAL ARTICLE; COMPLEMENT SYSTEM; CONFERENCE PAPER; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; HUMAN; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL;

BLOOD PRESSURE; BRADYKININ; CARDIOPULMONARY BYPASS; HUMANS; KININOGEN, HIGH-MOLECULAR-WEIGHT;

EID: 0032734069     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00072-7     Document Type: Conference Paper

References (5)

1. Bhoola, K.D., Figueroa, C.D., Worthy, K., 1992. Bioregulation of kinins: kallikrein, kininogens and kininases. Pharmacol. Rev. 44, 1-80.
2. Cugno, M., Cicardi, M., Agostoni, A., 1994. Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid. J. Allergy Clin. Immunol. 93, 870-876.
3. Downing, S.W., Edmunds, L.H. Jr., 1992. Release of vasoactive substances during cardiopulmonary bypass. Ann. Thorac. Surg. 54, 1236-1243.
4. Hall, R.I., Stafford Smith, M., Rocker, G., 1997. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth. Analg. 85, 766-782.
5. Nussberger, J., Cugno, M., Amstutz, C., Cicardi, M., Pellacani, A., Agostoni, A., 1998. Plasma bradykinin in angio-oedema. Lancet 351, 1693-1697.